Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for cancer (present status)

C Altaner1

  • 1Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia.

Neoplasma
|January 1, 1995
PubMed
Summary

Cancer gene therapy offers two main strategies: direct gene transfer to correct cancer genes and indirect gene transfer to enhance the immune response. Clinical trials explore various gene-based approaches for treating neoplastic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically engineered mesenchymal stromal cells in cancer gene therapy.

Bratislavske lekarske listy·2018
Same author

Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.

International journal of nanomedicine·2017
Same author

Exosomes of human mesenchymal stem/stromal/medicinal signaling cells.

Neoplasma·2017
Same author

Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma.

Neoplasma·2016
Same author

Stem cell based glioblastoma gene therapy.

Neoplasma·2012
Same author

Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation.

Neoplasma·2009

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunotherapy

Background:

  • Cancer gene therapy research is advancing, offering novel treatment modalities.
  • Current approaches focus on genetic manipulation to combat neoplastic diseases.
  • Understanding gene function is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To review the current status of cancer gene therapy.
  • To discuss primary gene therapy strategies for cancer treatment.
  • To summarize key clinical trials and future directions in the field.

Main Methods:

  • Review of direct gene therapy strategies (tumor suppressor gene insertion, oncogene suppression).
  • Analysis of indirect gene therapy strategies (enhancing immunogenicity).
  • Examination of clinical trials involving gene replacement, suicide/sensitivity genes, prodrug activation, and VDEPT.

Main Results:

  • Direct gene therapy aims to restore tumor suppressor function or inhibit oncogenes.
  • Indirect gene therapy enhances the host's immune response against cancer cells.
  • Clinical trials demonstrate diverse applications, including gene-drug combinations and stem cell protection.

Conclusions:

  • Cancer gene therapy presents promising strategies for neoplastic disease treatment.
  • Ongoing clinical trials are evaluating the efficacy of various gene-based interventions.
  • Future directions include refining existing methods and exploring novel gene therapy applications.

Related Experiment Videos